Stay updated on VTX958 vs Placebo in Psoriasis Treatment Clinical Trial
Sign up to get notified when there's something new on the VTX958 vs Placebo in Psoriasis Treatment Clinical Trial page.

Latest updates to the VTX958 vs Placebo in Psoriasis Treatment Clinical Trial page
- Check4 days agoChange DetectedAddition of Revision: v3.3.4 and deletion of Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a detailed Locations section listing study sites by state (AL, AZ, AR, CA, FL, GA, IN, KY, MD, MA, MI, MN, MO, NH, NC, OH, OR, SD, TN, TX, WA) and updated the record to Revision v3.3.3. Removed the HHS Vulnerability Disclosure element.SummaryDifference2%

- Check48 days agoChange DetectedRevision tag on the page changed to v3.3.2, replacing the previous v3.3.1.SummaryDifference0.0%

- Check55 days agoChange DetectedPage history shows a revision from v3.2.0 to v3.3.1. This appears to be a metadata update with no visible changes to the study data or criteria.SummaryDifference0.0%

- Check62 days agoChange DetectedRemoved the government funding status notice about potential delays and operating status from the page; core study details and enrollment information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check76 days agoChange DetectedNo additions or deletions detected; the study record content appears unchanged.SummaryDifference0.3%

Stay in the know with updates to VTX958 vs Placebo in Psoriasis Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VTX958 vs Placebo in Psoriasis Treatment Clinical Trial page.